Calumet (NASDAQ:CLMT) Director Sells $213,200.00 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $10.66, for a total transaction of $213,200.00. Following the completion of the sale, the director directly owned 101,959 shares of the company’s stock, valued at $1,086,882.94. This represents a 16.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Calumet Trading Down 10.8%

Calumet stock opened at $26.96 on Friday. Calumet, Inc. has a 1-year low of $7.68 and a 1-year high of $30.35. The firm’s fifty day simple moving average is $23.06 and its 200-day simple moving average is $19.95. The company has a market capitalization of $2.34 billion, a P/E ratio of -69.13 and a beta of 1.24.

Calumet (NASDAQ:CLMT) last posted its earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of ($3,098.50) million for the quarter, compared to analyst estimates of $1.04 billion. During the same period in the previous year, the company earned ($0.47) earnings per share. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. On average, equities research analysts predict that Calumet, Inc. will post -3.02 earnings per share for the current year.

Hedge Funds Weigh In On Calumet

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Calumet by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,703,040 shares of the oil and gas company’s stock valued at $93,449,000 after purchasing an additional 58,376 shares during the period. Two Seas Capital LP raised its position in shares of Calumet by 56.9% during the second quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock valued at $70,860,000 after buying an additional 1,631,098 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Calumet by 112.4% in the second quarter. Geode Capital Management LLC now owns 1,704,670 shares of the oil and gas company’s stock valued at $26,860,000 after buying an additional 901,933 shares during the period. Marshall Wace LLP lifted its stake in shares of Calumet by 35.8% in the third quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock valued at $16,268,000 after buying an additional 234,766 shares during the period. Finally, Bank of America Corp DE grew its position in Calumet by 3.4% during the second quarter. Bank of America Corp DE now owns 609,307 shares of the oil and gas company’s stock worth $9,600,000 after buying an additional 20,110 shares in the last quarter. 34.41% of the stock is currently owned by institutional investors and hedge funds.

Calumet News Roundup

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Q4 2025 Results
• Positive Sentiment: FY2025 operational / cash‑flow improvements — management highlighted Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, ~ $100M of cost savings driving free cash flow, and a Montana Renewables expansion on track for Q2 2026; these items materially lower financial risk and support valuation upside longer term. FY2025 Results & Commentary
• Neutral Sentiment: Analyst / preview coverage mixed — several firms updated targets and ratings (Goldman raised its PT; others remain hold/neutral), and the consensus price target (~$22.83) is below the recent trading level, leaving sentiment conflicted. Analyst Coverage Summary
• Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (including a recent 2,000‑share tranche and several 20k tranches earlier), materially trimming his stake; visible insider sales often weigh on investor confidence. Insider Trades Report
• Negative Sentiment: Rising short interest — short positions climbed in February to roughly 6.97M shares (~8.4% of float) with a ~4.4 days‑to‑cover, increasing the potential for continued selling pressure and intraday volatility. Short Interest Data

Analysts Set New Price Targets

A number of research analysts recently weighed in on CLMT shares. TD Cowen reissued a “hold” rating on shares of Calumet in a research note on Thursday, January 29th. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a research report on Monday, December 29th. UBS Group restated a “neutral” rating and issued a $26.00 price objective on shares of Calumet in a research note on Friday, February 13th. HC Wainwright reiterated a “buy” rating and issued a $33.00 target price on shares of Calumet in a research note on Monday, November 10th. Finally, The Goldman Sachs Group lifted their target price on shares of Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Calumet has an average rating of “Hold” and a consensus price target of $22.83.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.